<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE315nnn/GSE315421/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315421</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>In vivo antimicrobial therapeutic efficacy and immune homeostasis analysis of S. aureus peritonitis</name><description>Type-I photosensitization addresses the dilemma of intracellular bacterial hypoxia-induced photodynamic therapeutic (PDT) inefficacy, yet precise targeting and eradicating sequestered pathogens remains a formidable challenge. Herein, we engineer an albumin-based photodynamic conversion nanomedicine integrating target-specific recognition with controlled antibacterial functions to precisely eliminate intracellular pathogens and restore infected cell activity. Mechanistic studies reveal a vertically-crossed conformation that promotes intramolecular electron transfer and charge separation, redirecting photosensitizer (PS) reactivity toward type-I reactive oxygen species (ROS) generation. Electron-rich albumin further enhances cationic PS+• recycling, photostability and O2-• generation, while minimizing off-target organelle effects. We demonstrate application in S. aureus-infected sepsis showing high type-I ROS levels for antibacterial function from the nanomedicine to restore redox and immune homeostasis without noticeable toxicity. This work pioneers a strategy to convert ROS generation from type-II to type-I pathways for hypoxia-tolerant bacterial elimination, merging mechanistic precision with translational potential for clinical sepsis management.</description><dates><publication>2026/05/01</publication></dates><accession>GSE315421</accession><cross_references><GSM>GSM9427844</GSM><GSM>GSM9427847</GSM><GSM>GSM9427848</GSM><GSM>GSM9427845</GSM><GSM>GSM9427846</GSM><GSM>GSM9427849</GSM><GPL>19057</GPL><GSE>315421</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>